Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 20.75 AMA PRA Category 1 CreditsTM.
 
Physicians should claim only the credit commensurate with their participation in the activity.

Commercial Supporters

This activity is supported by educational grants from Celgene Corporation, Eisai Inc, Genentech, Novartis Pharmaceuticals Corporation, and Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

11th Annual International Congress on the Future of Breast Cancer

11th Annual International Congress on the Future of Breast Cancer®


Overview

The 11th Annual International Congress on The Future of Breast Cancer® is an educational and scientific meeting that focuses on the clinical implications of breast cancer genetic and phenotypic subtyping, as well as novel agents and strategies changing the future of breast cancer therapy. New data and promising studies that provide information about how to optimally individualize breast cancer therapy will be discussed, and controversial issues will be debated. The conference provides a unique opportunity for medical, surgical and radiation oncologists and other healthcare professionals to learn from and interact with international leaders in breast cancer in order to increase knowledge, apply new data to practice, and ultimately improve patient outcomes.

Target Audience

This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.


Learning Objectives

  • Incorporate current guidelines and recent data on local therapy, including new strategies for surgical and radiation therapy, into the treatment of patients with breast cancer
  • Integrate biomarkers, molecular assays, and other risk assessment tools in treatment decision-making for breast cancer when appropriate
  • Incorporate systemic therapies for breast cancer (including endocrine, cytotoxic, targeted, and bone-modifying agents) into individualized treatment plans for patients based upon an evaluation of efficacy and safety, as well as patient and tumor characteristics
  • Evaluate emerging clinical data regarding new agents and evolving strategies for the treatment of breast cancer, and apply clinical trial data appropriately in order to optimize the outcome of individual patients
  • Select eligible patients with breast cancer for promising clinical trials






Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
1234567
891011121314
15161718192021
22232425262728
293031
Filter By